Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.22M
-
Shares change
-
-25.1K
-
Total reported value, excl. options
-
$4.42M
-
Value change
-
-$184K
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$3.63
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q2 2019
14 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q2 2019.
Anixa Biosciences Inc - Common Stock (ANIX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.22M shares
of 37.9M outstanding shares and own 3.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (641K shares), UBS Group AG (234K shares), GEODE CAPITAL MANAGEMENT, LLC (102K shares), BlackRock Inc. (79.7K shares), NORTHERN TRUST CORP (59K shares), Bank of New York Mellon Corp (39.8K shares), SEGALL BRYANT & HAMILL, LLC (17.4K shares), MORGAN STANLEY (14.5K shares), RAYMOND JAMES & ASSOCIATES (10K shares), and JPMORGAN CHASE & CO (8.44K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.